Ballew Advisors »

Tonix Pharmaceuticals Hldg C shares owned by Ballew Advisors

Quarter-by-quarter ownership of Tonix Pharmaceuticals Hldg C (TNXP) shares owned by Ballew Advisors from 13F filings

Historical chart of Ballew Advisors investment in Tonix Pharmaceuticals Hldg C

Tip: Access up to 7 years of quarterly data

All positions including Tonix Pharmaceuticals Hldg C held by Ballew Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tonix Pharmaceuticals Hldg C by Ballew Advisors

Quarter filed Position value Share count Share price at filing
2024-12-31 $6.4k 25k 0.26